News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nash Duane
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2023 |
4
| Nash Duane (Executive Chairman) has filed a Form 4 on IMMUNIC, INC.|
Txns:
| Granted 132,000 options
@ $1.4, valued at
$184.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/22/2020 |
4
| Nash Duane (Executive Chairman) has filed a Form 4 on IMMUNIC, INC.|
Txns:
| Granted 120,000 options
@ $17, valued at
$2M
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| Nash Duane (Director) has filed a Form 4 on IMMUNIC, INC.|
Txns:
| Paid exercise price by delivering 7,930 shares
@ $7.1541, valued at
$56.7k
Sold 4,400 shares
@ $6.96, valued at
$30.6k
Exercised 22,157 restricted stock units
@ $0 |
|
| 07/24/2019 |
4
| Nash Duane (Director) has filed a Form 4 on IMMUNIC, INC.|
Txns:
| Granted 29,959 options
@ $13.63, valued at
$408.3k
|
|
| 01/14/2019 |
4
| Nash Duane (President) has filed a Form 4 on VITAL THERAPIES INC|
Txns:
| Disposed/sold 93,377 options to buy
@ $0.4284, valued at
$40k
Disposed/sold 23,344 options to buy
@ $0.4284, valued at
$10k
Disposed/sold 241,670 options to buy
@ $8, valued at
$1.9M
Disposed/sold 85,000 options to buy
@ $8.28, valued at
$703.8k
Disposed/sold 85,000 options to buy
@ $3.2, valued at
$272k
Disposed/sold 85,000 options to buy
@ $5, valued at
$425k
Granted 886,316 restricted stock units
@ $0 |
|
| 06/15/2018 |
4
| Nash Duane (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $11.14, valued at
$139.3k
|
|
| 06/11/2018 |
4
| Nash Duane (President) has filed a Form 4 on VITAL THERAPIES INC|
Txns:
| Granted 85,000 options to buy
@ $5, valued at
$425k
|
|
| 02/16/2018 |
4
| Nash Duane (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $14.62, valued at
$14.6k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Nash Duane (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 991 shares
@ $9.2021, valued at
$9.1k
|
|
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/07/2016 |
4
| Nash Duane (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,980 shares
@ $7.4841, valued at
$14.8k
|
|
| 06/20/2016 |
4
| Nash Duane (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $8.56, valued at
$107k
|
|
| 05/17/2016 |
4
| Nash Duane (President) has filed a Form 4 on VITAL THERAPIES INC|
Txns:
| Granted 85,000 options to buy
@ $8.28, valued at
$703.8k
|
|
|
|